jtt 501 has been researched along with bm 131246 in 1 studies
| Studies (jtt 501) | Trials (jtt 501) | Recent Studies (post-2010) (jtt 501) | Studies (bm 131246) | Trials (bm 131246) | Recent Studies (post-2010) (bm 131246) |
|---|---|---|---|---|---|
| 21 | 0 | 1 | 7 | 0 | 0 |
| Protein | Taxonomy | jtt 501 (IC50) | bm 131246 (IC50) |
|---|---|---|---|
| Peroxisome proliferator-activated receptor gamma | Homo sapiens (human) | 0.014 | |
| Peroxisome proliferator-activated receptor alpha | Homo sapiens (human) | 4.086 | |
| ATP-binding cassette sub-family C member 8 | Homo sapiens (human) | 0.014 | |
| ATP-sensitive inward rectifier potassium channel 11 | Homo sapiens (human) | 0.014 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Iwao, M; Onogi, S; Shibata, T; Shinkai, H; Tanaka, M; Uchida, I; Wakitani, K | 1 |
1 other study(ies) available for jtt 501 and bm 131246
| Article | Year |
|---|---|
Isoxazolidine-3,5-dione and noncyclic 1,3-dicarbonyl compounds as hypoglycemic agents.
Topics: 3T3 Cells; Animals; Blood Glucose; Cell Differentiation; Drug Evaluation, Preclinical; Hypoglycemic Agents; Insulin; Isoxazoles; L Cells; Male; Malonates; Mice; Oxazoles; Triglycerides | 1998 |